Galderma Group AG (GDERF)
OTC
Closed
Aug 21, 2026
Day's Range
221.5552 wk Range
165.00Overview - GDERF - Galderma Group AG
Key Statistics
Valuation
Enterprise Value
53.71B
P/E (Trailing)
‪66.16‬
Price / Sales (TTM)
‪8.75‬
Price / Book
‪6.31‬
EV / EBITDA
‪38.75‬
Profitability
Profit Margin
‪14.57%‬
Operating Margin
‪20.23%‬
Return on Assets
‪5.35%‬
Return on Equity
‪10.82%‬
Ownership
Shares Outstanding
234.56M
Float
131.26M
Held by Insiders
‪21.02%‬
Held by Institutions
‪48.21%‬
Price stats
Beta
‪-0.09‬
50-Day Avg
‪217.04‬
200-Day Avg
‪202.76‬
Dividends
Payout Ratio
‪12.11%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GDERF - Galderma Group AG
Peers - GDERF - Galderma Group AG
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - GDERF - Galderma Group AG
About
Galderma Group AG is a leading global dermatology company headquartered in Zug, Switzerland, founded in 1981. The company operates across three core business segments: injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio encompasses flagship brands including Dysport and Azzalure…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
